About fisher & paykel - FSPKF
Fisher & Paykel Healthcare Corp. Ltd. engages in the design, manufacture, and marketing of products and systems for use in acute and chronic respiratory care, surgery, and treatment of obstructive sleep apnea. It operates through the following geographical segments: North America, Europe, Asia Pacific, and Other. The Other segment includes New Zealand, Latin America, Africa, and the Middle East. The company was founded in 1969 and is headquartered in Auckland, New Zealand.
FSPKF At a Glance
Fisher & Paykel Healthcare Corp. Ltd.
15 Maurice Paykel Place
Auckland, Auckland 2013
| Phone | 64-9-574-0100 | Revenue | 1.20B | |
| Industry | Medical Specialties | Net Income | 223.90M | |
| Sector | Health Technology | 2025 Sales Growth | 12.055% | |
| Fiscal Year-end | 03 / 2026 | Employees | 7,535 | |
| View SEC Filings |
FSPKF Valuation
| P/E Current | 53.788 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 49.674 |
| Price to Sales Ratio | 9.334 |
| Price to Book Ratio | 10.395 |
| Price to Cash Flow Ratio | 34.43 |
| Enterprise Value to EBITDA | 28.806 |
| Enterprise Value to Sales | 9.282 |
| Total Debt to Enterprise Value | 0.008 |
FSPKF Efficiency
| Revenue/Employee | 159,403.263 |
| Income Per Employee | 29,714.312 |
| Receivables Turnover | 6.667 |
| Total Asset Turnover | 0.855 |
FSPKF Liquidity
| Current Ratio | 1.869 |
| Quick Ratio | 1.184 |
| Cash Ratio | 0.529 |
FSPKF Profitability
| Gross Margin | 62.931 |
| Operating Margin | 25.308 |
| Pretax Margin | 24.873 |
| Net Margin | 18.641 |
| Return on Assets | 15.939 |
| Return on Equity | 21.094 |
| Return on Total Capital | 19.344 |
| Return on Invested Capital | 20.205 |
FSPKF Capital Structure
| Total Debt to Total Equity | 8.109 |
| Total Debt to Total Capital | 7.501 |
| Total Debt to Total Assets | 6.01 |
| Long-Term Debt to Equity | 3.539 |
| Long-Term Debt to Total Capital | 3.273 |